Newbridge Financial Services Group’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$214K Buy
1,128
+709
+169% +$133K 0.03% 240
2026
Q1
$82.6K Sell
419
-1
-0.2% -$193 0.01% 342
2025
Q4
$77.1K Hold
420
0.01% 352
2025
Q3
$64.3K Hold
420
0.01% 467
2025
Q2
$58.6K Hold
420
0.01% 476
2025
Q1
$61.6K Buy
420
+1
+0.2% +$145 0.02% 336
2024
Q4
$54.9K Buy
+419
New +$58.7K 0.01% 383
2024
Q3
Sell
-400
Closed -$62.4K 692
2024
Q2
$62.4K Hold
400
0.02% 338
2024
Q1
$54.2K Buy
+400
New +$53K 0.02% 382
2023
Q4
Sell
-728
Closed -$98.6K 1161
2023
Q3
$98.6K Hold
728
0.05% 302
2023
Q2
$104K Sell
728
-114
-14% -$16.8K 0.05% 308
2023
Q1
$117K Sell
842
-54
-6% -$7.26K 0.06% 288
2022
Q4
$121K Sell
896
-79
-8% -$9.91K 0.07% 265
2022
Q3
$107K Buy
975
+2
+0.2% +$254 0.06% 287
2022
Q2
$129K Sell
973
-23
-2% -$3.02K 0.08% 229
2022
Q1
$132K Buy
996
+3
+0.3% +$360 0.06% 261
2021
Q4
$116K Buy
993
+472
+91% +$55.5K 0.05% 276
2021
Q3
$63K Buy
521
+15
+3% +$1.75K 0.04% 350
2021
Q2
$61K Hold
506
0.04% 377
2021
Q1
$50K Buy
506
+106
+27% +$10.7K 0.04% 399
2020
Q4
$40K Sell
400
-54
-12% -$5.72K 0.03% 372
2020
Q3
$50K Buy
+454
New +$50.5K 0.05% 317

Other funds holding AZN

Newbridge Financial Services Group's AZN Position: Q2 2026 in Review

Newbridge Financial Services Group increased its AstraZeneca (AZN) stake by 169% in Q2 2026, buying an estimated $133K and bringing the position to 1,128 shares worth $214K. The position accounts for 0.03% of the portfolio, ranked #240.

Newbridge Financial Services Group first reported a position in AZN in Q3 2020 and has held it in 22 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Newbridge Financial Services Group held 1,128 shares of AstraZeneca worth $214K as of Q2 2026.
  • Newbridge Financial Services Group bought 709 AstraZeneca shares in Q2 2026, an estimated $133K.
  • AstraZeneca made up 0.03% of Newbridge Financial Services Group's portfolio in Q2 2026, its #240 holding.
  • Newbridge Financial Services Group first reported a position in AstraZeneca in Q3 2020 and has held it in 22 quarters since.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.